DISCARDED
FDA 510(k) Cleared

MyoVista Insights

AI-enabled ECG Management System that supports triage and screening for cardiac abnormalities, enabling earlier intervention and better patient outcomes.

MyoVista Insights Software Interface - AI-ECG Analysis Dashboard

Powered by Advanced AI

Our machine learning algorithms analyze ECG signals at a depth impossible for the human eye, detecting subtle patterns that indicate early-stage cardiac dysfunction.

Deep Learning Analysis

Advanced neural networks that detect subtle patterns in ECG signals invisible to traditional analysis methods.

Real-time Results

Get comprehensive analysis results in under 60 seconds from the time of ECG acquisition.

EHR Integration

Seamless integration with Epic via HL7 FHIR for streamlined clinical workflows.

Detailed Reports

Comprehensive clinical reports with risk scores, findings, and actionable recommendations.

FDA Cleared

Regulatory clearance ensures the highest standards of safety and efficacy for clinical use.

Expert Support

Dedicated clinical support team to assist with implementation and ongoing optimization.

Conditions Detected

MyoVista Insights can detect a wide range of cardiac conditions with clinically validated accuracy.

87%

Diastolic Dysfunction

Early screening for HFpEF

91%

Low Ejection Fraction

LVEF < 40% screening

94%

Atrial Fibrillation

AFib and flutter triage

82%

Coronary Artery Disease

Significant CAD indicators

84%

Valve Disease

Valvular screening

96%

QT Prolongation

Long QT screening

88%

Left Ventricular Hypertrophy

LVH screening

79%

Pulmonary Hypertension

PH indicators

Ready to Improve Cardiac Detection?

See how 12 validated algorithms can help your clinicians detect cardiac dysfunction earlier. Schedule a 30-minute demo with our clinical team.

30-minute demo
Clinical evidence review
Custom pricing